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Abstract
Background: Mammalian oocytes acquire competence to be fertilized during meiotic maturation.
The protein kinase CDC2 plays a pivotal role in several key maturation events, in part through
controlled changes in CDC2 localization. Although CDC2 is involved in initiation of maturation, a
detailed analysis of CDC2 localization at the onset of maturation is lacking. In this study, the
subcellular distribution of CDC2 and its regulatory proteins cyclin B and SPDY in combination with
several organelle markers at the onset of pig oocyte maturation has been investigated.
Results: Our results demonstrate that CDC2 transiently associates with a single domain, identified
as a cluster of endoplasmic reticulum (ER) exit sites (ERES) by the presence of SEC23, in the cortex
of maturing porcine oocytes prior to germinal vesicle break down. Inhibition of meiosis resumption
by forskolin treatment prevented translocation of CDC2 to this ERES cluster. Phosphorylated
GM130 (P-GM130), which is a marker for fragmented Golgi, localized to ERES in almost all
immature oocytes and was not affected by forskolin treatment. After removal of forskolin from the
culture media, the transient translocation of CDC2 to ERES was accompanied by a transient
dispersion of P-GM130 into the ER suggesting a role for CDC2 in redistributing Golgi components
that have collapsed into ERES further into the ER during meiosis. Finally, we show that SPDY, rather
than cyclin B, colocalizes with CDC2 at ERES, suggesting a role for the CDC2/SPDY complex in
regulating the secretory pathway during oocyte maturation.
Conclusion: Our data demonstrate the presence of a novel structure in the cortex of porcine
oocytes that comprises ERES and transiently accumulates CDC2 prior to germinal vesicle
breakdown. In addition, we show that SPDY, but not cyclin B, localizes to this ERES cluster together
with CDC2.
Background
Fully grown immature mammalian oocytes are arrested at
the diplotene stage of meiotic prophase I. Oocyte matura-
tion is initiated in vivo when the mural granulosa cells
respond to the preovulatory luteinizing hormone surge,
or in vitro when oocytes are isolated from follicles [1].
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Germinal vesicle breakdown (GVBD) marks the onset of
nuclear maturation, which progresses into formation of
the first metaphase spindle, followed by extrusion of the
first polar body and formation of the second metaphase
spindle. At metaphase II, oocytes enter a second period of
meiotic arrest, which is maintained until fertilization.
Meiosis resumption is often characterized by the occur-
rence of GVBD, since this is the first clear morphological
event that takes place after release from meiotic inhibi-
tion. However, extensive rearrangements of components
within the ooplasm, known as cytoplasmic maturation
[2], already start to occur prior to GVBD [3].
Cytoplasmic maturation includes dynamic changes in the
distribution and integrity of the Golgi apparatus and
endoplasmic reticulum (ER) [4-6]. In somatic cells, the
Golgi apparatus is fragmented at the onset of mitosis and
starts to reform at telophase [7]. Two distinct views on the
mechanism of Golgi partitioning during mitotis have
been proposed [7,8]. One view holds that association of
Golgi fragments with the metaphase spindle allows equal
partitioning of Golgi components into the two daughter
cells [9-11]. The second view is based on the idea of a
dynamic Golgi apparatus, in which Golgi proteins contin-
uously cycle through the ER. Coat protein II (COPII)-
coated vesicles that traffic from ER to Golgi originate at
subdomains of the ER, known as ER exit sites (ERES). Ves-
icle formation at ERES is inhibited during mitosis as a
consequence of which cycling Golgi proteins become
trapped in the ER [12]. Golgi components are then
equally distributed into daughter cells together with the
ER and the Golgi is reformed from vesicles that form at
ERES when the ER export block is lifted at telophase
[13,14]. Although the general distribution of ER during
oocyte maturation has been studied extensively [15], a
function for ERES during oocyte maturation remains to be
elucidated. Evidence for a role of either of these two mech-
anisms in the control of Golgi dynamics during oocyte
meiosis is lacking. It is clear that cytoplasmic processes
constitute an integral part of both mitosis and meiosis,
and we therefore use the term 'meiosis resumption' to
indicate the moment when the first rearrangement of
components occurs within the oocyte in response to
release from the inhibitory influence of the follicular envi-
ronment.
In most cells, cell division cycle 2 (CDC2, also referred to
as cyclin-dependent kinase 1) complexes with cyclin B to
form M-phase promoting factor (MPF), a well known cen-
tral regulator of both mitotic and meiotic events. MPF reg-
ulates chromosome condensation, nuclear envelope
breakdown, and formation of metaphase spindles in both
somatic cells and oocytes, whereas transition from met-
aphase to anaphase requires inactivation of MPF [16]. In
mitotic cells, disassembly of Golgi and ERES are regulated
by CDC2 through phosphorylation of GM130 and p47,
respectively [17,18]. Despite the similarities in CDC2
functions during mitosis and meiosis, it is unclear
whether the activity of CDC2 exerts a similarly stringent
control over the integrity of the Golgi apparatus and ERES
in oocytes as it does in mitotic cells.
The activity of CDC2 during the meiotic divisions of por-
cine oocytes is known to be controlled by at least two reg-
ulatory proteins, i.e. cyclin B and speedy (SPDY) [19,20].
SPDY proteins have no homology to cyclins, but are
potent activators of CDC2 during early phases of oocyte
maturation [21]. CDC2 activity can alternatively be con-
trolled through phosphorylation of specific residues.
Compared to the CDC2/cyclin B complex, the activity of
CDC2 when complexed with SPDY is less sensitive to
phosphorylation [19]. Finally, CDC2 activity may be reg-
ulated by changing the subcellular distribution of CDC2
and/or its regulators [22]: Sequestration of CDC2 to sub-
cellular domains may prevent CDC2 from phosphorylat-
ing specific substrates or limit access of regulatory
proteins to CDC2. Conversely, concentration of CDC2 at
subcellular 'foci', such as the Golgi or ERES, could confer
spatio-temporal specificity to CDC2 function.
To establish the role of the subcellular (re-)distribution of
CDC2, and its regulatory proteins cyclin B and SPDY, in
the regulation of early oocyte maturation, we examined
their localization and the distribution of cell organelles
containing potential CDC2 target proteins during pig
oocyte maturation. The localization of these organelles
was investigated using antibodies raised against the ERES
marker SEC23, the Golgi marker GM130, and phosphor-
ylated GM130 (P-GM130), a marker for fragmented
Golgi. Our results demonstrate that CDC2 transiently
associates with a P-GM130-labeled structure in the cortex
of maturing porcine oocytes prior to GVBD. Using the
ERES marker SEC23, we show that this structure consists
of a cluster of ERES. Furthermore, our data on the distri-
bution of CDC2 and its regulatory protein SPDY in
oocytes suggest a role for the CDC2/SPDY complex in reg-
ulation of secretion during oocyte maturation.
Results
CDC2 accumulates in a single cortical structure in GV 
stage oocytes
To determine the subcellular distribution of CDC2,
oocytes were fixed after 0 or 24 h of in vitro maturation
(IVM), immuno-labeled and analyzed by confocal laser
scanning microscopy. At 0 h, we observed a single large
CDC2-containing cytoplasmic structure in the cortex of
~25% of GV oocytes (Fig. 1A). High magnification images
showed that this CDC2-positive structure was composed
of clustered smaller units (Fig. 1A'). Additionally, ~35%
of oocytes displayed CDC2 staining in the GV (Fig. 1B), aBMC Developmental Biology 2009, 9:8 http://www.biomedcentral.com/1471-213X/9/8
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pattern that rarely coincided with staining in a cortical
structure. Staining with an anti-PSTAIR antibody (Fig. 1C,
C'), which recognizes the cyclin-binding domain that is
conserved in all CDKs, including CDC2 [23], showed a
morphologically identical structure. As could be expected
from a broader specificity, PSTAIR-reactive antibodies
also labeled other intracellular areas, e.g. cytoplasmic
areas near the GV at the plasma membrane of the oocyte
(Fig. 1C). Labeling with control IgG from pre-immune
serum revealed sporadic non-specific small puncta (Fig.
1D). Specificity of the CDC2 and PSTAIR directed anti-
bodies was further supported by immunoblotting, which
revealed a single specific band at the expected 34 kDa
molecular weight in oocyte and HeLa cell lysates. Little if
any CDC2 and PSTAIR could be detected in the cumulus
cells isolated from cumulus-oocyte complexes, which is
probably due to low mitotic activity of these cells (Fig.
1E).
The rate of oocyte maturation in our experimental system
was consistent with those previously reported in IVM
studies using similar maturation conditions [24]: All
CDC2 accumulates in a single cortical structure in GV stage oocytes Figure 1
CDC2 accumulates in a single cortical structure in GV stage oocytes. (A, B) 0 h GV stage oocytes labeled for CDC2 
(green) and DNA (blue) showing CDC2-accumulation in the cortex of the oocyte (A) and in the GV (B). (C) 0 h GV stage 
oocyte showing PSTAIR labeling (green) and DNA (blue). PSTAIR also accumulates in a cortical domain. Arrows indicate the 
area that is shown enlarged in the insets (A', C'), and arrowheads denote the GV. (D) 0 h GV stage oocyte from the same 
experiment as the oocyte in A, labeled with mouse IgG (moIgG; green) and DNA marker (blue). The image was produced 
using the same confocal settings and enhancements as in A. All images are Z-projections of 3 consecutive confocal sections. 
Scale bars represent 20 μm in A-D, and 5 μm in A' and C'. (E) Western blot of CDC2 and PSTAIR on ~250 oocytes (o) and 
cumulus cells (c) collected during the denuding procedure of these oocytes showing a specific band at ~34 kDa. A HeLa cell 
lysate (h) was used as positive control. Molecular weight (kDa) is indicated on the left of each set of lanes. (F) Weighted mean 
percentage ± weighted SEM of GV stage oocytes that contained a CDC2-labeled cortical domain at 0 and 24 hours of matura-
tion in 3 independent experiments. Absolute numbers are indicated to the right of the bars (number of positive oocytes/total 
number of oocytes) and * denotes significant difference (P < 0.05).BMC Developmental Biology 2009, 9:8 http://www.biomedcentral.com/1471-213X/9/8
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oocytes were in GV stage directly after isolation (0 h; n =
103); after 24 h of culture (n = 67), 39 ± 5% of oocytes
were still in GV, while 61 ± 5% had progressed to MI or
MII; after 44 h of maturation (n = 56), 88 ± 4% of oocytes
were in MII stage. The association of CDC2 with the corti-
cal structure depended on the state of oocyte maturation,
since the percentage of GV oocytes containing a CDC2-
labeled structure was significantly reduced from 26 ± 2%
at 0 h to 9 ± 6% at 24 h of IVM (Fig. 1F), while this CDC2-
labeled structure was not observed in any oocytes that had
progressed to MI or MII. Taken together, these data dem-
onstrate that CDC2 associates with a single cortical struc-
ture prior to GVBD and suggest that this association is
transient.
CDC2 associates with ER exit sites
To identify the nature of these CDC2-labeled structures,
immature (0 h) oocytes were double-labeled for CDC2
and several other markers: SEC23, GM130, P-GM130, cal-
nexin, gamma-tubulin, NUP153, and mitotracker (see
Table 1). SEC23 is a component of the COPII complex,
which is involved in the formation of transport vesicles at
ERES. COPII-coated vesicles transfer cargo from ER to
Golgi and dissociate their coat after fission from ERES. In
0 h GV oocytes, half of the CDC2-labeled structures were
positive for SEC23 (Fig. 2A–C; IgG controls are shown in
D-F), identifying them as ERES. GM130 is a Golgi matrix
protein. At the onset of mitosis, GM130 is phosphorylated
by CDC2 resulting in fragmentation of the Golgi appara-
tus and redistribution of the GM130 protein [27]. Almost
all (95 ± 3%) CDC2-positive structures in 0 h GV oocytes
also labeled for P-GM130 (Fig. 3A–C; IgG controls are
shown in D-F). Calnexin is an ER-resident transmem-
brane protein, that localizes to the rough ER, but not to
ERES [26,30]. Accordingly, we observed calnexin in a
reticular pattern and at the nuclear envelope in 0 h GV
oocytes (Fig. 3H, I). Consistent with its absence at ERES,
calnexin was not found at CDC2-labeled cortical struc-
tures in any of the GV oocytes examined (Fig. 3G, I).
Finally, gamma-tubulin (Fig. 4A–C), which localizes to
microtubule organizing centers, mitotracker (Fig. 4D–I), a
marker for mitochondria, and NUP153 (Fig. 4J), one of
the nuclear pore complex proteins that localizes to the
nuclear membrane and to annulate lamellae, were not
observed at CDC2-labeled structures. These results indi-
cate that CDC2 accumulates in a specialized compartment
in the smooth ER that comprises ERES.
Inhibition of meiosis resumption prevents association of 
CDC2 with P-GM130-labeled ERES
In our lab, collecting, selecting, and denuding oocytes
requires approximately 2.5 h. Although oocytes in our
experimental 0 h condition are still at the GV stage, they
may already have resumed meiosis during this experimen-
tal interval. To prevent premature meiosis resumption
during oocyte isolation, cumulus-oocyte complexes were
collected in the presence of 100 μM forskolin [31]. For-
skolin stimulates the activity of adenylate cyclase, thus
raising the intracellular cAMP concentration. Under these
conditions, oocytes are maintained in prophase I arrest
[32]. The presence of forskolin during oocyte isolation
and denuding significantly reduced the occurrence of
CDC2-labeling at the ERES cluster in GV stage oocytes
(Fig. 5A), supporting the idea that CDC2 is recruited to
ERES early after meiosis resumption. Since maintenance
of meiotic arrest by forskolin is reversible [33], oocytes
were isolated in the presence of forskolin, and examined
at several time points after removal of forskolin from the
culture media (forskolin chase). The percentage of GV
oocytes containing CDC2-labeled ERES increased within
2 h of chase (Fig. 5B, D), followed by a decline to ~10%
after 18 h of chase. In 0 h forskolin treated oocytes, the
occurrence of P-GM130-labeled ERES equaled that in 0 h
controls. A gradual decline in the percentage of GV
oocytes containing P-GM130-labeled ERES was observed
after forskolin removal (Fig. 5C, E). Combined, these
results indicate that P-GM130 accumulates at ERES prior
to meiosis resumption, and that CDC2 transiently associ-
Table 1: Listing of markers used to establish the identity of cortical structures in immature oocytes.
Name Type Target Reference Present in a cortical structure
CDC2 mouse monoclonal antibody Cell division cycle 2, catalytic subunit of MPF [22] +
PSTAIR mouse monoclonal antibody Cyclin binding domain in all Cdks [23] +
SEC23 goat polyclonal antibody SEC23, component of the coat protein II 
complex
[18] +
P-GM130 rabbit polyclonal antibody GM130 phosphorylated on serine 25 [27] +
Calnexin rabbit polyclonal antibody Calnexin, transmembrane protein [26] -
Gamma-tubulin rabbit polyclonal antibody Gamma-tubulin, cytoskeletal component [25] -
Mitotracker* Fixable live cell dye Oxidation within mitochondria [28] -
NUP153 mouse monoclonal antibody Nucleoporin 153 kDa [29] -
GM130 mouse monoclonal antibody Structural Golgi protein [27] -
Cyclin B mouse monoclonal antibody Cyclin B, regulatory subunit of MPF [22] -
SPDY rabbit polyclonal antibody SPDY, regulatory protein of CDC2 [19] +
* Stained by 30 min incubation in maturation medium prior to fixation.BMC Developmental Biology 2009, 9:8 http://www.biomedcentral.com/1471-213X/9/8
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ates with ERES just after the oocyte is released from the
inhibitory influence of the follicle.
Phosphorylated GM130 is stored at ERES during 
maturation
Given the role of CDC2 in phosphorylating the Golgi pro-
tein GM130, labeling for both GM130 and P-GM130
should provide information on the role of CDC2-labeled
cortical domains in Golgi-protein redistribution during
meiosis. To establish the distribution of GM130 and its
phosphorylated form P-GM130 during oocyte matura-
tion, oocytes were double-labeled for GM130 and P-
GM130 after 0, 24, and 44 h of IVM. GM130 staining
revealed an intact Golgi apparatus and several GM130-
labeled areas in the periphery of 0 h GV oocytes, whereas
GM130 was not detected in CDC2-labeled ERES (Fig. 6A).
As maturation progressed, GM130 staining in the oocyte
was observed in progressively smaller and more dispersed
fragments, whereas intact GM130-labeled Golgi com-
plexes were observed in the cumulus cells (Fig. 6A, D, G).
Staining for GM130 and P-GM130 did not overlap (Fig.
6C, F, I). At the GV stage, P-GM130 localized to a cortical
domain (Fig. 6B, C). P-GM130 labeling persisted in the
cortical domain in MI and MII stage oocytes, and
increased in the ER as maturation progressed (Fig. 6E, H,
J). No P-GM130 staining was detected in the polar body
CDC2 associates with ER exit sites Figure 2
CDC2 associates with ER exit sites. (A-C) 0 h GV stage oocyte labeled for CDC2 (A, green), DNA (A, blue), and SEC23 
(B, red). Colocalization (yellow) of CDC2 and SEC23 in a cortical domain in the ooplasm is evident in the merged image (C). 
(D-F) 0 h GV stage oocyte from the same experiment as A-C, labeled with mouse IgG (moIgG, D, green), DNA-marker (D, 
blue), and normal goat serum (NGS, E, red). Aspecific dots of moIgG staining (examples are marked with white circles in D, F) 
and NGS (examples are marked with yellow circles in E, F) do not colocalize in the merged image (F). Confocal sections from 
an acquisition depth equivalent to A-C are shown, and enhancements of D-F were identical to A-C. Images are Z-projections 
of 6 consecutive sections; scale bars represent 20 μm in C and F, and 5 μm in C'. Arrows indicate the region of the oocyte that 
is shown enlarged in the insets (A'-C'). Arrowheads denote the position of the GV.BMC Developmental Biology 2009, 9:8 http://www.biomedcentral.com/1471-213X/9/8
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Figure 3 (see legend on next page)BMC Developmental Biology 2009, 9:8 http://www.biomedcentral.com/1471-213X/9/8
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(Fig. 6H, I). These data indicate that during oocyte matu-
ration, GM130 is stored in the ER in its phosphorylated
form.
CDC2 associates with SPDY at ERES
The activity of CDC2 during cell division has been studied
most extensively as MPF, a complex of CDC2 and cyclin
B. Recently, evidence has been obtained that CDC2 activ-
ity in porcine oocytes can alternatively be controlled by
SPDY, a protein with no homology to cyclin B [19]. Here,
we used a combination of staining approaches to identify
the regulatory component of CDC2 during early phases of
maturation. Interestingly, we found that SPDY was
present in CDC2-positive ERES in 0 h GV oocytes (Fig.
7A–C). Since simultaneous labeling of oocytes for cyclin
B and CDC2 was not possible due to the same host species
of cyclin B and CDC2 antibodies, we used an alternative
approach in which we identified ERES by the presence of
P-GM130. Oocytes (0 h, GV) double-labeled for P-
GM130 and cyclin B showed no cyclin B in P-GM130-
labeled ERES (0/21). Instead, about half of the oocytes
(10/21) showed clear cyclin B labeling in the GV (Fig. 7D–
F). Consistent with these observations, anti-PSTAIR anti-
bodies, which do not detect CDC2 when bound to cyclin
B [23], labeled P-GM130-containing ERES (11/18),
whereas PSTAIR was not observed in the GV of any of the
oocytes examined (0/18; Fig. 7G–I). These results indicate
that CDC2 at ERES associates with SPDY, but not cyclin B,
at the onset of oocyte maturation.
Discussion
Here, we show that the cell-cycle regulating protein CDC2
transiently associates with a cluster of ERES at the onset of
oocyte maturation, and propose that this association is
involved in Golgi retention. Detailed microscopical anal-
ysis of large numbers of oocytes showed that during the
initial phases of in vitro maturation, CDC2 localized to a
large (~7 μm diameter) structure, that was exclusively
observed in the cortex, in about a quarter of GV oocytes
(Fig. 1A, F). The ERES marker SEC23 colocalized with
CDC2 in about half of these cortical domains (Fig 2A–C),
demonstrating that at least some of these CDC2-positive
compartments consist of active ERES. A morphologically
identical domain labeled for the CDC2 target protein P-
GM130 was observed in ~80% of 0 h GV stage oocytes
(Fig. 6J), and almost all CDC2-labeled cortical domains
also labeled for P-GM130. In addition to this morpholog-
ical likeness, only one P-GM130-labeled domain was
observed per oocyte and this domain was always found in
a cortical position. These identical features of SEC23,
CDC2, and/or P-GM130-labeled domains indicate that all
of these domains were composed of ERES, albeit mostly
inactive ERES, since the majority was devoid of SEC23
labeling.
Membrane trafficking, and thus association of SEC23 with
ERES, is inhibited during mitosis in somatic cells [12-14],
which may in part be due to disassembly of ERES [18].
Upon disassembly, ERES-resident proteins disperse into
the ER where they remain until the ERES are reformed at
the start of interphase [18]. Our results support this view,
since P-GM130 disperses from the ERES-containing
domain into the ER prior to GVBD (Fig. 5C, E and fig. 6B,
E, H). However, P-GM130 localization at the cortical
domain was observed in >80% of oocytes at MI and MII
(Fig. 6J). No difference in either morphology or position
within the oocyte could be observed throughout matura-
tion using P-GM130 as a marker for this domain (Fig. 6).
Therefore, it can be inferred that the P-GM130-labeled
domain is composed of ERES throughout maturation.
When compared to ERES described in most somatic cells
and bovine oocytes [6,18], the cortical domain in porcine
oocytes is exceptionally large. Since SEC23 was not found
outside the cortical domain (Fig. 2B), we conclude that
most if not all ERES are clustered together in the cortex at
this stage. The presence of this single cluster of ERES has
not been reported before and appears to be a unique fea-
ture of oocytes.
During pre-GVBD IVM, the percentage of GV oocytes con-
taining CDC2-labeled ERES decreased significantly (Fig.
1D). When the onset of maturation was prevented by iso-
The fragmented Golgi marker P-GM130 colocalizes with CDC2 at ERES in immature oocytes Figure 3 (see previous page)
The fragmented Golgi marker P-GM130 colocalizes with CDC2 at ERES in immature oocytes. (A-C) 0 h GV 
stage oocyte labeled for CDC2 (A, green), DNA (A, blue), and phosphorylated GM130 (B, red). Colocalization (yellow) of 
CDC2 and phosphorylated GM130 in a cortical compartment in the ooplasm is evident in the merged image (C). (D-F) 0 h GV 
stage oocyte from the same experiment as A-C, labeled with moIgG (D, green), DNA-marker (D, blue), and rabbit IgG (raIgG, 
E, red). None of the aspecific dots (examples are marked with white circles in D, F and yellow circles in E, F) colocalize in the 
merged image (F). This control image was subjected to the same enhancements as A-C, and selected to show confocal sections 
from an equivalent acquisition depth. (G-I) 0 h GV stage oocyte labeled for CDC2 (G, green), DNA (G, blue), and the ER-
marker calnexin (H, red). No colocalization (yellow) of CDC2 and calnexin was observed in the merged image (I). Images are 
Z-projections of 6 consecutive sections (A-F), or 3 consecutive sections (G-I); scale bars represent 20 μm in C, F, and I, and 5 
μm in C' and I'. Arrows indicate the region of the oocyte that is shown enlarged in the insets (A'-C' and G'-I'). Arrowheads 
denote the position of the GV.BMC Developmental Biology 2009, 9:8 http://www.biomedcentral.com/1471-213X/9/8
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lating COCs in the presence of the adenylate cyclase-stim-
ulating drug forskolin, the occurrence of CDC2-labeled
ERES was significantly decreased (Fig. 5A), demonstrating
that CDC2 translocation to and accumulation at ERES is
initiated upon release from meiotic inhibition. This
CDC2 translocation may therefore constitute the first sign
of meiosis resumption. CDC2 accumulation at ERES was
transient since the occurrence of CDC2-labeled ERES
increased within 2 h after release from forskolin-main-
tained meiotic arrest, and subsequently declined to a
much lower level after 18 h of maturation (Fig. 5B, D).
CDC2-labeled ERES could not be detected in oocytes that
had undergone GVBD, indicating that CDC2 accumula-
tion, and hence CDC2 activity, at ERES is specific for pre-
GVBD stages. Transient localization of CDC2 at ERES
would also explain the discrepancy between the occur-
rence of the CDC2- (~25%; Fig. 1F) and the P-GM130-
labeled (~80%; Fig. 5C and 6J) ERES cluster in immature
oocytes. These results corroborate the proposition that
stage dependent translocation of CDC2 underlies specific
spatial and temporal control of CDC2 activity within
oocytes [34-36].
It is evident from studies on somatic cells that CDC2 is
involved in fragmentation and partitioning of the Golgi
during early phases of mitosis [27]. Golgi fragmentation is
initiated by CDC2-dependent phosphorylation of the
membrane-resident Golgi protein GM130 [17], followed
by vesiculation of the collapsing cisternae [37]. In our
experiments, the presence of forskolin during oocyte iso-
lation did not change the occurrence of P-GM130-labeled
ERES at 0 h (Fig. 5C, E), indicating that P-GM130 accumu-
lation at ERES precedes meiosis resumption. The percent-
age of GV oocytes with a P-GM130-containing ERES
cluster declined from 80% in forskolin-inhibited 0 h
matured oocytes to 35% at 18 h of maturation after for-
skolin removal (Fig. 5C). When oocytes were matured for
longer intervals, i.e. 24 or 44 h, the percentage of oocytes
showing a P-GM130-containing ERES cluster equaled that
of the 0 h controls (Fig. 6J), whereas CDC2 did not local-
ize at ERES clusters in MI (24 h) and MII (44 h) oocytes.
These data indicate that the transient presence of CDC2 is
closely followed by a transient absence of P-GM130 at
ERES, prior to GVBD. Given the role of CDC2 in control-
ling ERES disassembly at the onset of mitosis [18], we pro-
pose that CDC2 controls dispersion of P-GM130 from
ERES into the reticular ER.
Two models on Golgi partitioning during cell division are
currently prevalent in literature. One model claims that
Golgi inheritance occurs independently from the ER by
association of Golgi-derived vesicles with the developing
spindle, which facilitates subsequent equal partitioning of
these Golgi fragments during telophase [7]. In the other
model, known as the ER-dependent model, Golgi pro-
teins redistribute into the ER during metaphase and Golgi
stacks are reformed in daughter cells upon reinitiation of
ER export [8]. In our experimental model, most oocytes
contained a P-GM130-labeled ERES cluster immediately
after isolation and at MI and MII (Fig. 6J), whereas P-
GM130 was completely absent in the region surrounding
the metaphase plates at both MI and MII (Fig. 6E, H).
Staining of the non-phosphorylated form of GM130 in
the oocyte showed an increasingly dispersed pattern as
maturation progressed (Fig. 6A, D, G), and P-GM130
staining in the ER increased relative to staining in ERES
(Fig. 6B, E, H), suggesting that phosphorylation of
GM130 and redistribution of P-GM130 into the ER con-
tinues after meiosis resumption. Phosphorylation of
Golgi-resident GM130 presumably triggers efficient trans-
location of this protein into the ER, because the distribu-
tions of GM130 and P-GM130 were mutually exclusive in
porcine oocytes (Fig. 6C, F, I). Taken together, these
results indicate that Golgi inheritance in oocytes occurs
through redistribution of Golgi components into the ER,
and thus support an ER-dependent model in oocytes.
Our data indicate that CDC2 at ERES was not complexed
with cyclin B (Fig. 7D–I). Instead, we observed SPDY at
CDC2-labeled ERES (Fig. 7A–C), suggesting that SPDY
regulates CDC2 activity at ERES. Although we cannot con-
clude directly from our data that SPDY associates with
Gamma-tubulin, mitochondria, and NUP153 do not associate with ERES Figure 4 (see previous page)
Gamma-tubulin, mitochondria, and NUP153 do not associate with ERES. (A-C) 0 h GV stage oocyte labeled for 
CDC2 (A, green), DNA (A, blue), and gamma-tubulin (B, red). The CDC2-labeled ERES cluster did not label with gamma-tubu-
lin (C). (D-F) 0 h GV stage oocyte labeled for CDC2 (D, green), DNA (D, blue), and mitochondria, using the mitochondrial 
marker mitotracker (E, red). Mitotracker did not label CDC2-positive ERES (F). (G-I) Confocal section through the same 
oocyte as in D-F showing the GV. Note that the much lower staining intensity in G-I compared to D-F is solely the result of a 
~65 μm change in depth of imaging, since acquisition settings and image enhancement were identical between these images. (J) 
0 h GV stage oocyte labeled for NUP153 (green) and DNA (blue). None of the oocytes examined (0/15) showed a cortical 
domain. The 3 separate double lines around the GV are the result of small size and shape changes between the 3 consecutive 
sections used to produce the image. Images are either Z-projections of 3 consecutive sections (A-C, J), or single sections (D-I); 
scale bars represent 20 μm in C, F, I, and J. Arrows indicate CDC2-labeled ERES, and arrowheads denote the position of the 
GV.BMC Developmental Biology 2009, 9:8 http://www.biomedcentral.com/1471-213X/9/8
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Inhibition of meiosis resumption prevents association of CDC2 with P-GM130-labeled ERES Figure 5
Inhibition of meiosis resumption prevents association of CDC2 with P-GM130-labeled ERES. (A) Weighted mean 
percentage ± weighted SEM of GV stage oocytes containing CDC2-labeled ERES clusters after treatment with either DMSO 
(0h-c) or 100 μM forskolin (0h-F) during the isolation procedure. Data from 3 separate experiments is shown and * indicates 
significant difference (P < 0.05). Absolute numbers are shown next to the bars (number of positive oocytes/total number of 
oocytes). (B, C) Forskolin chase bar graphs (n = 3; 20–30 oocytes per group), showing the weighted mean percentage ± 
weighted SEM of GV stage oocytes containing a cluster of ERES, labeled for CDC2 (B) and/or P-GM130 (C). In one of the 
experiments shown, an equal percentage of CDC2-labeled ERES was observed in 0h-F and 0h-c groups. As a result, the differ-
ence between 0h-c and 0h-F is significant in A, but not in B. The original dichotomous data (presence/absence of an ERES clus-
ter) was analyzed in SPSS using binary logistic regression. All groups were compared to 0h-c and 0h-F conditions for a total of 
10 comparisons per label. The familywise significance level was set to 0.05, and was adjusted for pairwise comparisons using 
the Holm-Bonferroni procedure. Significant differences compared to 0h-c or 0h-F are indicated by * or +, respectively. (D, E) 
Representative example of a forskolin chase experiment from the series of experiments shown in B, C, showing the percentage 
of GV stage oocytes containing a cluster of ERES, labeled for CDC2 (D) and/or P-GM130 (E). Note that the increase in the 
occurrence of CDC2-labeled ERES at 0.5 h after release from forskolin-maintained inhibition of maturation (D) is obscured in 
the chart showing combined data from three experiments (B), because it occurred at varying time points. Conditions on the y-
axis are: 0 h DMSO control (0h-c), 0 h forskolin (0h-F), and 0.5, 1, 2, and 18 h of maturation after forskolin removal (0.5 h/1 h/
2 h/18 h).
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Phosphorylated GM130 is stored at ERES during maturation Figure 6
Phosphorylated GM130 is stored at ERES during maturation. Oocytes were stained for GM130 (green), P-GM130 
(red), and DNA (blue) at different maturation stages. (A-C) 0 h GV stage oocyte containing a perinuclear Golgi apparatus 
(arrowhead). (D-F) 24 h matured MI oocyte containing a metaphase plate (arrowhead). (G-I) 44 h matured MII oocyte showing 
the second metaphase plate (arrowhead) and a polar body (yellow arrowhead). Arrows indicate the area that is shown 
enlarged in the insets. Z-projections of 3 (A-F) or 6 (G-I) consecutive sections are shown; scale bars represent 20 μm in C, F 
and I, and 5 μm in C' F' and I'. Arrows indicate the region of the oocyte that is shown enlarged in the insets (A'-I'). (J) Weighted 
mean percentage ± weighted SEM of oocytes that contain a P-GM130-labeled cortical domain at the indicated maturation 
times. Results from 2 independent experiments are shown.BMC Developmental Biology 2009, 9:8 http://www.biomedcentral.com/1471-213X/9/8
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CDC2 associates with SPDY at ERES Figure 7
CDC2 associates with SPDY at ERES. (A-C) 0 h GV stage oocyte labeled for CDC2 (A, green), DNA (A, blue), and SPDY 
(B, red). Both CDC2 and SPDY localize to the same cortical domain (C). Note that the center of this oocyte is dented (the 
area that contains the arrow) causing the structure to appear in the middle of the oocyte, whereas it is located in the cortex. 
(D-F) 0 h GV stage oocyte stained for Cyclin B (D, green), DNA (D, blue), and P-GM130 (E, red). Cyclin B did not localize to 
the P-GM130-labeled cortical domain (F). (G-I) 0 h GV stage oocyte labeled for PSTAIR (G, green), DNA (G, blue), and P-
GM130 (H, red). Spatial overlap of PSTAIR and phosphorylated GM130 staining (yellow) in a cortical domain is evident in the 
merged image (I). Images are Z-projections of 2 (A-C) or 3 (D-I) consecutive sections; scale bars represent 20 μm in C, F, and 
I, and 5 μm in C', F', and I'. Arrows indicate the region of the oocyte that is shown enlarged in the insets (A'-I'). Arrowheads 
denote the position of the GV.BMC Developmental Biology 2009, 9:8 http://www.biomedcentral.com/1471-213X/9/8
Page 13 of 16
(page number not for citation purposes)
CDC2 at ERES, additional evidence that SPDY may be a
key regulatory protein of CDC2 upstream of MPF in por-
cine oocytes is provided by the observation that (1)
CDC2/cyclin B activity can only be detected in a histone
H1 kinase assay after 18–24 h of maturation [38-41] and
that (2) injection of SPDY mRNA into oocytes accelerates
oocyte maturation by stimulating MPF [21].
Our identification of a specialized cortical ERES-contain-
ing domain prompted us to compare it to similar struc-
tures described for other species. Morphologically, this
cortical domain resembles Organized Smooth ER (OSER),
which consists of stacked membrane arrays [42]. In our
study, the ER-resident protein calnexin could not be
detected in the CDC2-containing domain (Fig. 3G–I),
indicating that this domain does not consist of reticular
ER. In Xenopus laevis oocytes, cyclin B was found to local-
ize to annulate lamellae, which may constitute one of the
forms of OSER in immature oocytes [29]. Our studies
show that neither the annulate lamellae marker NUP153
(Table 1, fig. 4J), nor cyclin B (Fig. 7A–C), localize to the
cortical domain in immature porcine oocytes, suggesting
that this domain does not consist of OSER or annulate
lamellae. Primordial oocytes of several species contain an
aggregate of organelles, the Balbiani body, which resem-
bles the CDC2-labeled domain in size and in that there is
only one of these bodies per oocyte. The Balbiani body
contains components of several organelles including
mitochondria, Golgi, and ER, and dissipates after the pri-
mordial stage [43]. P-GM130-labeled cortical domains
were devoid of markers for intact Golgi (Fig. 6A, D, G) and
mitochondrial markers (Table 1, fig. 4D–I), showing that
the cortical domain and the Balbiani body are unrelated
structures.
Based on observations in mitotic cells and our data from
porcine oocytes, we hypothesize that prior to meiosis
resumption, GM130 at the Golgi is phosphorylated by
CDC2 [17,27] and subsequently transferred to ERES.
Upon initiation of oocyte maturation, CDC2 activity at
ERES may result in dissociation of SEC23-containing
coats and consequent cessation of vesiculation [18,44].
Other protein complexes that control ERES function may
also be phosphorylated [45], allowing dispersion of P-
GM130 into the reticular ER, as observed for the ERES
transmembrane marker Yip1A-GFP in CHO cells [18].
This mechanism could prevent recycling of GM130 back
to the fragmenting Golgi and in this way facilitate com-
plete Golgi breakdown. As pre-GVBD maturation pro-
ceeds, CDC2 is transported away from ERES (Fig. 1F),
which may result in the renewed recruitment of P-GM130
to ERES (Fig. 6J). Since reformation of Golgi complexes at
ERES has been observed in somatic cells [12-14], storage
of P-GM130 in a cluster of ERES may allow for highly effi-
cient and local reformation of the Golgi apparatus once
the metaphase block of ER export is lifted after fertiliza-
tion.
Conclusion
In this study, we have observed a novel domain in the cor-
tex of porcine oocytes that comprises a cluster of ERES. We
found that the well-known meiotic regulator CDC2 tran-
siently localizes to this domain during pre-GVBD matura-
tion, immediately after the oocyte is released from the
inhibitory influence of the follicular environment. Our
data further suggest that CDC2, in conjunction with its
regulatory protein SPDY, plays a role in regulating storage
of structural Golgi elements at this ERES cluster. The early
role of the CDC2/SPDY complex described here adds to
the available evidence [21] that points to a role for CDC2/
SPDY upstream of MPF during oocyte maturation. Finally,
these findings demonstrate that pre-GVBD maturation
comprises not only a set of changes in chromatin config-
uration [46], but also controlled and highly local events
within the cytoplasm of the oocyte, that may be important
in regulating the secretory system during the meiotic divi-
sions.
Methods
Reagents and antibodies
All chemicals were purchased from Sigma Chemical Co.
(St. Louis, MO, USA), unless otherwise indicated. The fol-
lowing antibodies and reagents were used (concentration
or dilution and catalog number in brackets): mouse mon-
oclonal anti-CDC2 (1 μg/ml; sc-54) and goat polyclonal
anti-SEC23 (2 μg/ml; sc-12107) from Santa Cruz Biotech-
nologies (Santa Cruz, CA, USA); rabbit polyclonal anti-
Calnexin (1:250; SPA-860) from Stressgen Biotechnolo-
gies (San Diego, CA, USA); mouse monoclonal anti-
PSTAIR (1 μg/ml; ab10345, which is directed against
EGVPSTAIREISLLKE, a conserved region in cyclin-
dependent kinases (CDKs) [23,47]) and rabbit polyclonal
anti-gamma-tubulin (1:1000; ab11321) from Abcam
(Cambridge, UK); mouse monoclonal anti-NUP153 (4
μg/ml; MMS-102P) from Covance (Berkeley, CA, USA);
mouse monoclonal anti-GM130 (1 μg/ml; G65120) and
mouse monoclonal anti-cyclin B1 (5 μg/ml; 554179)
from BD Biosciences (San Jose, CA, USA); rabbit polyclo-
nal anti-SPDY (2.2 μg/ml; NB100–2521, directed against
a conserved region that is present in both isoforms) from
Novus Biologicals (Littleton, CO, USA); Mitotracker Deep
Red (200 nM; M22426), goat anti-mouse IgG alexa488,
goat anti-rabbit IgG alexa568, and rabbit anti-goat IgG
alexa488 (20 μg/ml; A11029, A11036, and A11078,
respectively) from Molecular Probes (Eugene, OR, USA);
donkey anti-mouse IgG Cy3 (6.25 μg/ml; 715-165-151)
from Jackson ImmunoResearch Laboratories Inc. (West
Grove, PA, USA); rabbit polyclonal anti-P-GM130 (1:100;
detects GM130 phosphorylated on serine 25 [27]) was aBMC Developmental Biology 2009, 9:8 http://www.biomedcentral.com/1471-213X/9/8
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generous gift from Dr. Martin Lowe (University of Man-
chester, UK).
Collection, culture, and assessment of porcine cumulus 
oocyte complexes
Cumulus-oocyte complexes (COCs) were collected from
sow (Sus scrofa) ovaries, obtained from a slaughterhouse,
by aspiration of 3–6 mm follicles [48] and subsequently
selected using well established morphological criteria
[49]. In vitro maturation (IVM) was performed as previ-
ously described [48], with the exception that media were
not covered with oil. Briefly, COCs were collected in
HEPES buffered M199 and washed in M199 (Gibco BRL)
supplemented with 2.2 mg/ml NaHCO3, 0.1% (w/v) pol-
yvinylpyrrolidone (PVP), 100 μM cysteamine, 75 μg/ml
potassium penicillin G and 50 μg/ml streptomycin sul-
phate (oocyte maturation medium; OMM) [49-51], and
equilibrated in a CO2 incubator (38.5°C; 5% CO2) for at
least 2 h before use. Selected COCs were cultured at
38.5°C under 5% CO2 for 22 h in OMM supplemented
with 0.05 IU/ml recombinant human FSH (rhFSH; a kind
gift from Organon, Oss, the Netherlands). When COCs
were cultured beyond 22 h, the medium was replaced
with OMM without FSH (24 h and 44 h culture condi-
tions). Based on overall morphology and DNA staining
pattern that was assessed by confocal laser scanning
microscopy (see below), in vitro matured COCs were sub-
divided into three categories: germinal vesicle (GV), mei-
osis I (MI; indicated by the presence of a metaphase plate,
anaphase I and telophase I stages were included in this
group), and meiosis II (MII; as indicated by the presence
of a metaphase plate and the first polar body). Oocytes
that could not be scored or showed an aberrant morphol-
ogy and did not fit any of the above criteria were excluded
from statistical analyses.
Inhibition of meiosis resumption by forskolin treatment
COCs were kept in DMSO (control; 1:500) or 100 μM for-
skolin (50 mM forskolin in DMSO diluted 1:500) [31]
during isolation and selection. Next, oocytes were
denuded in DMSO or forskolin, fixed, and stained for
CDC2 and DNA. In forskolin chase experiments, COCs
treated with forskolin during isolation and selection were
washed and cultured in OMM without forskolin for 0.5, 1,
2, or 18 h, and subsequently denuded and fixed. Finally,
all groups were labeled for CDC2, P-GM130, and DNA,
and the presence of structures was assessed using confocal
laser scanning microscopy (as described below).
Immunofluorescence staining for confocal laser scanning 
microscopy
After culture, COCs were washed in 80 mM PIPES, 5 mM
EGTA, 2 mM MgCl2, pH 6.8, supplemented with 0.3% (w/
v) PVP (PEM-PVP) at 37°C. To minimize mechanical
stress that accompanies denudation procedures, but
maintain sufficient antibody penetration after fixation,
oocytes were partially denuded by gentle pipetting in
PEM-PVP supplemented with either 0.01% (w/v) pronase
(for < 22 h cultured oocytes), or 0.1% (w/v) hyaluroni-
dase (for ≥ 22 h cultured oocytes). After washing in PEM-
PVP at 37°C, oocytes were fixed in freshly prepared PEM-
PVP containing 4% (v/v) paraformaldehyde (PF; Electron
Microscopy Sciences, Hatfield, PA, USA) at room temper-
ature (RT) for 1 h. Fixed oocytes were stored in PEM-PVP
containing 1% (v/v) PF at 4°C for up to one week. For
immunolabeling, oocytes were washed twice in PBS (0.1
M; pH 7.4) containing 0.3% (w/v) PVP (PBS-PVP) and
once in PBS containing 0.1% (w/v) saponin (PBS-S) for 5
min. Aspecific binding sites were blocked using 1% (w/v)
BSA and either 2% (v/v) normal goat serum, or 2% (v/v)
normal horse serum (when goat polyclonal anti-SEC23
was used), both from Vector Lab (Burlingame, CA, USA),
in PBS-S (blocking buffer) supplemented with 100 mM
glycine for 2 h at RT or overnight at 4°C. Subsequent
immunolabeling steps were performed sequentially in
blocking buffer for 1 h at RT and followed by three rinses
in PBS-S for 10 min each. Primary and secondary anti-
body dilutions were centrifuged at 100,000 g for 1 h
before use. As negative controls, all experiments included
5–10 oocytes that were incubated with purified mouse
IgG combined with rabbit IgG or normal goat serum
matching the host species of primary antibodies used as
appropriate. Control IgG concentrations and serum dilu-
tions were identical to primary antibodies in the same
experiment. DNA was labeled with 10 μM TO-PRO-3
iodide (Molecular Probes) in PBS-S for 20 min. After a
final three washes in PBS-S, oocytes were mounted in a
0.12 mm 8 well Secure-Seal Spacer (Molecular Probes) on
a coverslip, covered in Vectashield (Vector Lab), and
sealed with a microscope slide (Superfrost Plus; Menzel,
Braunschweig, Germany).
Image acquisition and analysis
Images were obtained through a 40× oil immersion objec-
tive (N.A. 1.3) using a BioRad Radiance 2100 MP confocal
system (Zeiss/BioRad, Hertfordshire, UK), equipped with
488, 543, and 637 nm lasers, or a Leica TCS SP2 confocal
system (Leica Microsystems GmbH, Wetzlar, Germany),
equipped with 488, 568, and 633 nm lasers. Dual and tri-
ple channel images were obtained by sequential scanning.
ImageJ (NIH; http://rsb.info.nih.gov/ij/) image analysis
software was used for qualitative analysis of images. Laser
power and acquisition settings were adjusted to produce
submaximal pixel values in the oocyte and settings used to
image control IgG stainings were matched to the highest
settings used to image primary antibody staining in the
same experiment. Consecutive confocal sections were
taken at 4 μm intervals. Scoring of the structures described
in this paper was performed by sequential scanning
through oocytes from top to bottom in live view modeBMC Developmental Biology 2009, 9:8 http://www.biomedcentral.com/1471-213X/9/8
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and noting the presence or absence of a structure. When a
structure was present, sections through both structure and
DNA were taken, whereas only DNA-containing sections
were taken in oocytes that did not contain a structure.
Images were selected based on the presence of DNA and a
structure within 6 consecutive sections to clearly show
both maturation stage and presence of a structure in a sin-
gle image. Background subtraction and contrast/bright-
ness enhancement (up to ~20% enhancement using the
maximum slider in imageJ) were performed on stacks of
images, followed by maximum intensity Z-projection of
consecutive sections to include both the structure and the
region of the oocyte that contained chromatin. Contrast/
brightness enhancement of IgG controls was identical to
images from the same experiment.
SDS-PAGE and Western blot
Oocytes were completely denuded by vortexing for 15
min in PBS-PVP containing protease inhibitor (Roche
Molecular Biochemicals, Almere, the Netherlands).
Denuded oocytes were separated from cumulus cells by
two consecutive washes. Leftover cumulus cells were col-
lected by centrifugation of the cumulus-containing sus-
pension for 15 min at 16,000 g, and oocytes were
collected by centrifugation for 5 min at 16,000 g. After
removal of the supernatant, the cumulus cells and oocytes
were snap-frozen in liquid nitrogen and stored at -20°C.
Positive controls consisted of HeLa cells that were grown
to near confluence and collected by centrifugation in PBS
containing protease inhibitor (Roche). Cells were resus-
pended in 62.5 mM Tris-HCl, 2% SDS, and 10% glycerol
(SDS sample buffer) to a concentration of 5 × 106 cells/ml
and snap-frozen in liquid nitrogen. After addition of SDS
sample buffer to oocyte and granulosa cell samples, all
samples were incubated at 100°C for 5 min. Proteins were
separated on 10% polyacrylamide gels (30 μl/slot) by
SDS-PAGE and transferred to Polyvinylidene Fluoride
membranes (Hybond-P; GE Healthcare Amersham Bio-
sciences Europe Gmbh, Freiburg, Germany), which were
subsequently blocked in PBS containing 0.1% Tween-20
(PBST) supplemented with 5% (w/v) non-fat milk pow-
der (Protifar; Nutricia, Zoetermeer, the Netherlands), and
incubated in antibody dilutions in PBST containing 0.5%
(w/v) Protifar. Primary antibodies were probed using
horseradish peroxidase-conjugated goat anti-mouse anti-
bodies (Jackson ImmunoResearch Laboratories Inc.,
Westgrove, PA, USA) and detected by Supersignal west
pico chemiluminescent substrate (Pierce Biotechnology,
Rockford, IL, USA).
Statistical analysis
Data are presented as weighted mean percentage ±
weighted SEM of oocytes, unless otherwise indicated. Sta-
tistical analysis was performed on the original dichoto-
mous data in SPSS 12.0 (SPSS Inc., Chicago, IL, USA)
using chi-square tests unless otherwise indicated.
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